Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martijn P W Intven

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
BMJ Open|September 24, 2024
Feasibility, safety and preliminary efficacy of preoperative stereotactic radiotherapy on the future pancreatic neck transection margin to reduce the risk of pancreatic fistula after high-risk pancreatoduodenectomy (FIBROPANC): protocol for a multicentre, single-arm trialJ Annelie Suurmeijer, Leonoor V Wismans, Tessa E Hendriks, et al.
The Lancet. Oncology|February 19, 2026
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort studyTimo F W Soeterik, Marcin Miszczyk, Max Peters, et al.
Abdominal Radiology (New York)|November 27, 2025
MKNet-family architectures for auto-segmentation of the residual pancreas after pancreatic resection: a deep learning comparative studyDennis Böhm, Paul C M Andel, Paul A Akkermans, et al.
Clinical and Translational Radiation Oncology|June 4, 2024
Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocolGuus Grimbergen, Hidde Eijkelenkamp, Louk M W Snoeren, et al.
Surgery|March 6, 2024
Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysisLeonoor V Wismans, J Annelie Suurmeijer, Jelle C van Dongen, et al.
Cancers|February 27, 2026
The Value of Stereotactic Radiotherapy After FOLFIRINOX in Patients with Pancreatic Cancer with Vascular Contact-A Nationwide, Retrospective Cohort StudyFreek R van 't Land, Leonard W F Seelen, Maaike Verheij, et al.
International Journal of Radiation Oncology, Biology, Physics|April 29, 2023
Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence RatesTania C Sluckin, Sanne-Marije J A Hazen, Karin Horsthuis, et al.
Annals of Surgery|August 11, 2020
Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide AnalysisLois A Daamen, Vincent P Groot, Marc G Besselink, et al.
JAMA Oncology|December 21, 2023
Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological OutcomesSanne-Marije J A Hazen, Tania C Sluckin, Martijn P W Intven, et al.
Annals of Surgical Oncology|November 7, 2025
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal AdenocarcinomaPaul C M Andel, Iris W J M van Goor, Thijs J Schouten, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
BMJ Open|September 24, 2024
Feasibility, safety and preliminary efficacy of preoperative stereotactic radiotherapy on the future pancreatic neck transection margin to reduce the risk of pancreatic fistula after high-risk pancreatoduodenectomy (FIBROPANC): protocol for a multicentre, single-arm trialJ Annelie Suurmeijer, Leonoor V Wismans, Tessa E Hendriks, et al.
The Lancet. Oncology|February 19, 2026
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort studyTimo F W Soeterik, Marcin Miszczyk, Max Peters, et al.
Abdominal Radiology (New York)|November 27, 2025
MKNet-family architectures for auto-segmentation of the residual pancreas after pancreatic resection: a deep learning comparative studyDennis Böhm, Paul C M Andel, Paul A Akkermans, et al.
Clinical and Translational Radiation Oncology|June 4, 2024
Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocolGuus Grimbergen, Hidde Eijkelenkamp, Louk M W Snoeren, et al.
Surgery|March 6, 2024
Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysisLeonoor V Wismans, J Annelie Suurmeijer, Jelle C van Dongen, et al.
Cancers|February 27, 2026
The Value of Stereotactic Radiotherapy After FOLFIRINOX in Patients with Pancreatic Cancer with Vascular Contact-A Nationwide, Retrospective Cohort StudyFreek R van 't Land, Leonard W F Seelen, Maaike Verheij, et al.
International Journal of Radiation Oncology, Biology, Physics|April 29, 2023
Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence RatesTania C Sluckin, Sanne-Marije J A Hazen, Karin Horsthuis, et al.
Annals of Surgery|August 11, 2020
Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide AnalysisLois A Daamen, Vincent P Groot, Marc G Besselink, et al.
JAMA Oncology|December 21, 2023
Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological OutcomesSanne-Marije J A Hazen, Tania C Sluckin, Martijn P W Intven, et al.
Annals of Surgical Oncology|November 7, 2025
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal AdenocarcinomaPaul C M Andel, Iris W J M van Goor, Thijs J Schouten, et al.
Pageof 8